Channel Robotics is developing a patented handheld AI-enabled endoscopic robotic platform designed to deliver robotic-level dexterity through existing flexible endoscopes. The company aims to expand access to advanced endoscopic procedures by avoiding large capital-intensive robotic systems and enabling use across hospitals, ambulatory surgery centers, and community practices. Channel plans to continue prototype refinement, expand engineering and product development, and advance manufacturing and quality systems ahead of regulatory submission. Management targets an FDA submission in 2027 and is preparing for commercial launch following regulatory clearance. Financially, Channel has raised a total of $4.6 million across a $2.1 million Seed and a $2.5 million Seed+ led by True Ventures, which will fund the company’s near-term development and regulatory milestones. Founded by Dr. Philip Weissbrod and Dr. Michael Yip, the company emphasizes practical, scalable robotic solutions that integrate into existing clinical workflows.

Total raised

$3M

Funding rounds

1

Latest round

Seed

Latest activity

Jun 2026